Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1997 2
1999 1
2000 2
2003 5
2004 1
2005 2
2006 1
2008 2
2009 3
2010 2
2011 6
2012 2
2013 3
2014 3
2016 1
2017 2
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
18F-Florbetaben PET beta-amyloid binding expressed in Centiloids.
Rowe CC, Doré V, Jones G, Baxendale D, Mulligan RS, Bullich S, Stephens AW, De Santi S, Masters CL, Dinkelborg L, Villemagne VL. Rowe CC, et al. Among authors: mulligan rs. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2053-2059. doi: 10.1007/s00259-017-3749-6. Epub 2017 Jun 22. Eur J Nucl Med Mol Imaging. 2017. PMID: 28643043 Free PMC article.
(18)F-florbetaben Aβ imaging in mild cognitive impairment.
Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chételat G, Raniga P, Mulligan RS, Salvado O, Putz B, Roth K, Masters CL, Reininger CB, Rowe CC. Ong K, et al. Among authors: mulligan rs. Alzheimers Res Ther. 2013 Jan 16;5(1):4. doi: 10.1186/alzrt158. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 23324163 Free PMC article.
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals.
van der Kall LM, Truong T, Burnham SC, Doré V, Mulligan RS, Bozinovski S, Lamb F, Bourgeat P, Fripp J, Schultz S, Lim YY, Laws SM, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Maruff P, Masters CL, Villemagne VL, Rowe CC. van der Kall LM, et al. Among authors: mulligan rs. Neurology. 2021 Feb 2;96(5):e662-e670. doi: 10.1212/WNL.0000000000011222. Epub 2020 Nov 12. Neurology. 2021. PMID: 33184233 Free PMC article.
Quantitative approaches to amyloid imaging.
Villemagne VL, O'Keefe G, Mulligan RS, Rowe CC. Villemagne VL, et al. Among authors: mulligan rs. Methods Mol Biol. 2011;680:201-25. doi: 10.1007/978-1-60761-901-7_14. Methods Mol Biol. 2011. PMID: 21153383
Limbic selectivity of clozapine.
Pilowsky LS, Mulligan RS, Acton PD, Ell PJ, Costa DC, Kerwin RW. Pilowsky LS, et al. Among authors: mulligan rs. Lancet. 1997 Aug 16;350(9076):490-1. doi: 10.1016/S0140-6736(05)63079-6. Lancet. 1997. PMID: 9274589 No abstract available.
Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC. Villemagne VL, et al. Among authors: mulligan rs. J Nucl Med. 2011 Aug;52(8):1210-7. doi: 10.2967/jnumed.111.089730. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764791 Free article.
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.
Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, Rigopoulos A, Cartwright GA, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, Kudo Y, Cappai R, Yanai K, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: mulligan rs. Brain. 2011 Apr;134(Pt 4):1089-100. doi: 10.1093/brain/awr038. Epub 2011 Mar 24. Brain. 2011. PMID: 21436112
In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N. Villemagne VL, et al. Among authors: mulligan rs. Eur J Nucl Med Mol Imaging. 2014 May;41(5):816-26. doi: 10.1007/s00259-013-2681-7. Epub 2014 Feb 11. Eur J Nucl Med Mol Imaging. 2014. PMID: 24514874
In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: mulligan rs. Eur J Pharmacol. 2009 Sep 1;617(1-3):54-8. doi: 10.1016/j.ejphar.2009.06.042. Epub 2009 Jul 1. Eur J Pharmacol. 2009. PMID: 19576880
40 results